Home/Filings/4/0001013606-19-000021
4//SEC Filing

Mahboob Vaseem 4

Accession 0001013606-19-000021

CIK 0001013606other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 9:01 PM ET

Size

7.3 KB

Accession

0001013606-19-000021

Insider Transaction Report

Form 4
Period: 2018-12-30
Mahboob Vaseem
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-12-30+470,115616,927 total
  • Award

    Option to Purchase

    2018-12-30$0.74/sh+225,621$167,975225,621 total
    Exercise: $0.74From: 2019-12-30Exp: 2028-12-30Common Stock (225,621 underlying)
Footnotes (2)
  • [F1](i) 201,478 time-based restricted stock units (RSUs) vest in two equal annual installments on December 30, 2019 and December 30, 2020, and (ii) 268,637 RSUs vest as to 100% of the underlying shares on December 30, 2021, provided that the vesting of the RSUs shall be subject to acceleration based on the achievement of specified Company and/or individual performance criteria to be approved by the Company's compensation committee. All RSUs granted shall settle in shares of common stock on each of the dates indicated.
  • [F2]100% of the option award shall vest on December 30, 2019.

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeother

Related Parties

1
  • filerCIK 0001655157

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:01 PM ET
Size
7.3 KB